在N蛋白中SARS-CoV-2的特定适应抑制NF-κB的激活和改变病变发生
Xiao Guo1, Shimin Yang1, Zeng Cai2
1State Key Laboratory of Virology, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
The Journal of cell biology
|December 16, 2024
概括
与SARS-CoV-2核体蛋白质不同,SARS-CoV-2核体蛋白质阻断核因子-κB (NF-κB) 途径的激活,与SARS-CoV核体蛋白质不同. 在SARS-CoV-2中,特定的氨基酸变化是这种病原性差异的关键.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 和SARS-CoV导致不同的炎症反应和肺损伤.
- 这些差异背后的精确分子机制在很大程度上是未知的.
研究的目的:
- 阐明SARS-CoV-2和SARS-CoV.之间的炎症途径激活的差异机制.
- 为了确定负责这些独特的病原性影响的特定病毒蛋白成分.
主要方法:
- 研究了SARS-CoV-2和SARS-CoV核体 (N) 蛋白与核因子-κB (NF-κB) 信号通路的相互作用.
- 利用比较性氨基酸序列分析确定了SARS-CoV-2 N蛋白质中的关键残留物.
- 在细胞和动物模型中使用SARS-CoV-2转补系统验证的发现.
主要成果:
- 发现SARS-CoV-2 N蛋白质通过破坏转化生长因子β激活激酶1 (TAK1) -TAK1结合蛋白2/3 (TAB2/3) 复合组合来抑制NF-κB通路激活.
- SARS-CoV N 蛋白质对 NF-κB 途径没有表现出抑制作用.
- 在SARS-CoV-2 N蛋白的C端域中,氨基酸残留物Glu-290和Gln-349被确定为其抑制功能的关键.
结论:
- 与SARS-CoV相比,N蛋白中的特定氨基酸差异显著导致SARS-CoV-2的明显炎症反应和病原性.
- 了解这些分子区别,可以深入了解病毒病原和潜在的治疗点.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
RNA Polymerase II Accessory Proteins
9.1K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.1K
Single Nucleotide Polymorphisms-SNPs
14.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.0K


